A View LCS vs Study Watch with Irregular Pulse Monitor (Home)

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

AVIEW LCS

by Coreline Soft

Study Watch with Irregular Pulse Monitor (Home)

by Verily Health

AI Verdict

Tool A is an AI-powered medical imaging platform designed for comprehensive thoracic CT analysis, focusing on lung cancer screening, emphysema, and coronary artery calcification. In contrast, Tool B is a wearable device for unobtrusive physiological data collection, specializing in ECG and irregular pulse monitoring for conditions like atrial fibrillation. While both leverage AI in cardiology, their distinct data sources (CT scans vs. wearable sensors) and primary applications make them suitable for different clinical needs.

Choose AVIEW LCS if…

Choose A View LCS if your clinical practice requires a comprehensive, AI-powered platform for detailed thoracic CT analysis, integrating lung cancer screening, emphysema quantification, and coronary artery calcification scoring from a single low-dose CT scan. This tool is ideal for radiologists and pulmonologists seeking automated nodule detection, volume quantification, and comprehensive report generation to streamline diagnostic workflows and enhance early disease detection.

View AVIEW LCS →

Choose Study Watch with Irregular Pulse Monitor (Home) if…

Choose Study Watch with Irregular Pulse Monitor (Home) if you are conducting clinical research or require unobtrusive, continuous remote monitoring of physiological data, particularly for early detection of atrial fibrillation. This prescription-only wearable is best suited for healthcare providers needing to collect long-term ECG and irregular pulse data from patients in a home setting, leveraging cloud-based analytics for insights into cardiac health.

View Study Watch with Irregular Pulse Monitor (Home) →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature	AVIEW LCS	Study Watch with Irregular Pulse Monitor (Home)
Pricing	Subscription or one-off payment	Unknown
Deployment	Cloud-based, Hybrid solution, Locally on dedicated hardware, Locally virtualized (virtual machine, Docker)	Unknown
FDA Status	Cleared AI-estimated	Unknown
HIPAA	Yes AI-estimated	Unknown

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

AVIEW LCS

AVIEW LCS directly enhances clinician usability by automating comprehensive thoracic CT analysis and report generation, streamlining existing radiology workflows. Its flexible deployment options also support easier integration into diverse healthcare IT environments, making it more adaptable for clinical users.

Clinical Value

AVIEW LCS

AVIEW LCS provides comprehensive diagnostic support for multiple critical conditionsu2014lung cancer, emphysema, and coronary artery diseaseu2014from a single low-dose CT scan, offering broad clinical utility. Its FDA clearance further validates its diagnostic capabilities for these significant health concerns.

Pricing & Value

Tie

Both tools require direct contact for pricing information, making it impossible to assess their relative value propositions without specific cost details. The lack of public pricing transparency for either product prevents a meaningful comparison in this dimension.

Enterprise Readiness

AVIEW LCS

AVIEW LCS demonstrates strong enterprise readiness with clear HIPAA compliance and flexible deployment options, including cloud, hybrid, and on-premise solutions. In contrast, Verily Study Watch has a reported lawsuit alleging HIPAA breaches, which raises significant concerns for enterprise adoption and data security trust.

Innovation

AVIEW LCS

AVIEW LCS demonstrates high innovation through its ability to perform comprehensive analysis for lung cancer, emphysema, and coronary artery calcification from a single low-dose CT scan. Its unique CT kernel conversion AI technology further enhances diagnostic consistency and efficiency across varied imaging protocols.

Support & Docs

Tie

Neither the provided structured facts nor readily available public information offer sufficient details regarding the scope, accessibility, or quality of support and documentation for either AVIEW LCS or Verily Study Watch. Therefore, a comparative assessment is not possible.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature	AVIEW LCS	Study Watch with Irregular Pulse Monitor (Home)
Name	A View LCS	Study Watch with Irregular Pulse Monitor (Home)
Company	Coreline Soft Co.	Verily Life Sciences LLC
Description	AVIEW LCS by Coreline Soft is an FDA-cleared AI-powered medical imaging platform for comprehensive thoracic CT analysis, specializing in lung cancer screening, emphysema quantification, and coronary artery calcification detection from a single low-dose CT scan.	The Verily Study Watch with Irregular Pulse Monitor (Home) is a prescription-only wearable device for clinical research and healthcare use, designed to unobtrusively collect physiological data, including ECG and irregular pulse monitoring, with advanced sensors and cloud-based analytics.
Categories	Cardiology AI, Oncology AI, Radiology & Imaging AI	Cardiology AI, Wearables & Remote Monitoring (RPM)
Specialties	Cardiology, Pulmonology, Radiology	Cardiology, Family Medicine, Internal Medicine

Videos

Demos, reviews, and walkthroughs featuring AVIEW LCS and Study Watch with Irregular Pulse Monitor (Home).

Loading videos…

Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

What are the primary clinical applications of each tool?

AVIEW LCS is an AI-powered medical imaging platform for comprehensive thoracic CT analysis, specializing in lung cancer screening, emphysema quantification, and coronary artery calcification detection from a single low-dose CT scan. The Verily Study Watch with Irregular Pulse Monitor (Home) is a prescription-only wearable device designed to unobtrusively collect physiological data, including on-demand single-channel ECG measurement and irregular pulse monitoring for atrial fibrillation (AFib) detection.

How do the data collection methods and modalities differ between A View LCS and the Study Watch?

AVIEW LCS processes medical images from CT scans to provide AI-powered analysis for various thoracic conditions. In contrast, the Study Watch is a wearable device that directly collects physiological data, such as ECG and irregular pulse, from the patient, with subsequent cloud-based data processing.

Which medical specialties are these tools primarily designed to support?

AVIEW LCS is primarily designed for Cardiology, Pulmonology, and Radiology due to its focus on thoracic CT image analysis. The Study Watch is intended for use in Cardiology, Family Medicine, and Internal Medicine, mainly for cardiac monitoring and physiological data collection.

What specific cardiac health features does each tool offer?

AVIEW LCS provides Coronary Artery Calcium (CAC) scoring using Agatston, volume, and mass scores, along with segmentation of major coronary arteries from CT scans. The Study Watch offers on-demand single-channel ECG measurement and irregular pulse monitoring specifically for atrial fibrillation (AFib) detection.

Are there any unique regulatory or usage requirements for either device?

AVIEW LCS is an FDA-cleared AI-powered medical imaging platform. The Verily Study Watch is an FDA-cleared, prescription-only wearable device intended for clinical research and healthcare use, not direct consumer sale.